112 related articles for article (PubMed ID: 17239598)
1. Efficient synthesis and biological evaluation of omega-oxygenated analogues of vitamin K2: study of modification and structure-activity relationship of vitamin K2 metabolites.
Suhara Y; Murakami A; Kamao M; Mimatsu S; Nakagawa K; Tsugawa N; Okano T
Bioorg Med Chem Lett; 2007 Mar; 17(6):1622-5. PubMed ID: 17239598
[TBL] [Abstract][Full Text] [Related]
2. Design and synthesis of biologically active analogues of vitamin K2: evaluation of their biological activities with cultured human cell lines.
Suhara Y; Hirota Y; Nakagawa K; Kamao M; Tsugawa N; Okano T
Bioorg Med Chem; 2008 Mar; 16(6):3108-17. PubMed ID: 18171617
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel vitamin K2 analogues with modification at the ω-terminal position and their biological evaluation as potent steroid and xenobiotic receptor (SXR) agonists.
Suhara Y; Watanabe M; Nakagawa K; Wada A; Ito Y; Takeda K; Takahashi K; Okano T
J Med Chem; 2011 Jun; 54(12):4269-73. PubMed ID: 21561094
[TBL] [Abstract][Full Text] [Related]
4. Vitamins K2, K3 and K5 exert antitumor effects on established colorectal cancer in mice by inducing apoptotic death of tumor cells.
Ogawa M; Nakai S; Deguchi A; Nonomura T; Masaki T; Uchida N; Yoshiji H; Kuriyama S
Int J Oncol; 2007 Aug; 31(2):323-31. PubMed ID: 17611688
[TBL] [Abstract][Full Text] [Related]
5. Structure-activity relationships in the conversion of vitamin K analogues into menaquinone-4. Substrates essential to the synthesis of menaquinone-4 in cultured human cell lines.
Suhara Y; Wada A; Tachibana Y; Watanabe M; Nakamura K; Nakagawa K; Okano T
Bioorg Med Chem; 2010 May; 18(9):3116-24. PubMed ID: 20378364
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity relationship of novel menaquinone-4 analogues: modification of the side chain affects their biological activities.
Suhara Y; Hanada N; Okitsu T; Sakai M; Watanabe M; Nakagawa K; Wada A; Takeda K; Takahashi K; Tokiwa H; Okano T
J Med Chem; 2012 Feb; 55(4):1553-8. PubMed ID: 22250752
[TBL] [Abstract][Full Text] [Related]
7. QSAR of molecular structure and cytotoxic activity of vitamin K2 derivatives with concept of absolute hardness.
Ishihara M; Sakagami H
Anticancer Res; 2007; 27(6B):4059-63. PubMed ID: 18225571
[TBL] [Abstract][Full Text] [Related]
8. Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.
Ozaki I; Zhang H; Mizuta T; Ide Y; Eguchi Y; Yasutake T; Sakamaki T; Pestell RG; Yamamoto K
Clin Cancer Res; 2007 Apr; 13(7):2236-45. PubMed ID: 17404108
[TBL] [Abstract][Full Text] [Related]
9. Vitamin K2-mediated apoptosis in cancer cells: role of mitochondrial transmembrane potential.
Shibayama-Imazu T; Aiuchi T; Nakaya K
Vitam Horm; 2008; 78():211-26. PubMed ID: 18374196
[TBL] [Abstract][Full Text] [Related]
10. Tumor-specificity and type of cell death induced by vitamin K2 derivatives and prenylalcohols.
Sakagami H; Hashimoto K; Suzuki F; Ishihara M; Kikuchi H; Katayama T; Satoh K
Anticancer Res; 2008; 28(1A):151-8. PubMed ID: 18383839
[TBL] [Abstract][Full Text] [Related]
11. Synthetic Small Molecules Derived from Natural Vitamin K Homologues that Induce Selective Neuronal Differentiation of Neuronal Progenitor Cells.
Suhara Y; Hirota Y; Hanada N; Nishina S; Eguchi S; Sakane R; Nakagawa K; Wada A; Takahashi K; Tokiwa H; Okano T
J Med Chem; 2015 Sep; 58(17):7088-92. PubMed ID: 26305288
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxic activity of vitamins K1, K2 and K3 against human oral tumor cell lines.
Okayasu H; Ishihara M; Satoh K; Sakagami H
Anticancer Res; 2001; 21(4A):2387-92. PubMed ID: 11724297
[TBL] [Abstract][Full Text] [Related]
13. Systematic synthesis and anti-inflammatory activity of ω-carboxylated menaquinone derivatives--Investigations on identified and putative vitamin K₂ metabolites.
Fujii S; Shimizu A; Takeda N; Oguchi K; Katsurai T; Shirakawa H; Komai M; Kagechika H
Bioorg Med Chem; 2015 May; 23(10):2344-52. PubMed ID: 25858455
[TBL] [Abstract][Full Text] [Related]
14. Vitamin K2 induces phosphorylation of protein kinase A and expression of novel target genes in osteoblastic cells.
Ichikawa T; Horie-Inoue K; Ikeda K; Blumberg B; Inoue S
J Mol Endocrinol; 2007 Oct; 39(4):239-47. PubMed ID: 17909264
[TBL] [Abstract][Full Text] [Related]
15. Comparative uptake, metabolism, and utilization of menaquinone-4 and phylloquinone in human cultured cell lines.
Suhara Y; Murakami A; Nakagawa K; Mizuguchi Y; Okano T
Bioorg Med Chem; 2006 Oct; 14(19):6601-7. PubMed ID: 16798001
[TBL] [Abstract][Full Text] [Related]
16. Chemoprevention of chemically-induced biliary carcinogenesis in hamsters by vitamin K2.
Tsuchida A; Itoi T; Kasuya K; Nagakawa Y; Suzuki M; Ikeda T; Suzuki Y; Aoki T; Miyazawa K
Hepatogastroenterology; 2011; 58(106):290-7. PubMed ID: 21661384
[TBL] [Abstract][Full Text] [Related]
17. [Experience of vitamin K2 in Thailand].
Bunyaratavej N
Clin Calcium; 2007 Nov; 17(11):1752-60. PubMed ID: 17982197
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis, and biological evaluation of artificial macrosphelides in the search for new apoptosis-inducing agents.
Matsuya Y; Kobayashi Y; Kawaguchi T; Hori A; Watanabe Y; Ishihara K; Ahmed K; Wei ZL; Yu DY; Zhao QL; Kondo T; Nemoto H
Chemistry; 2009 Jun; 15(23):5799-813. PubMed ID: 19370747
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of the mechanism producing menaquinone-4 in osteoblastic cells.
Suhara Y; Wada A; Okano T
Bioorg Med Chem Lett; 2009 Feb; 19(4):1054-7. PubMed ID: 19167887
[TBL] [Abstract][Full Text] [Related]
20. Successful therapy of myelodysplastic syndrome with menatetrenone, a vitamin K2 analog.
Takami A; Nakao S; Ontachi Y; Yamauchi H; Matsuda T
Int J Hematol; 1999 Jan; 69(1):24-6. PubMed ID: 10641439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
